Literature DB >> 24696735

Brain metastasis of ALK positive anaplastic large cell lymphoma after a long-term disease free survival in an old adult.

Cai-Xia Wang1, Hai Wang1, Jie Li2, Heng-Hui Ma1, Bo Yu1, Shan-Shan Shi1, Xiao-Jun Zhou1, Qun-Li Shi1.   

Abstract

Anaplastic large cell lymphoma (ALCL) is a subtype of non-Hodgkin lymphoma composed of CD30-positive cells and now recognized as three different entities: primary cutaneous ALCL, primary systemic anaplastic lymphoma kinase (ALK)-positive (ALK+) ALCL and primary ALK-negative (ALK-) ALCL. ALK+ ALCL is supposed to have a better prognosis than ALK- ALCL. It is rarely metastasized to other sites, especially to the central nervous system (CNS). Herein, we present a rare case of systemic ALK+ ALCL which metastasized to the brain after a long-term disease free survival in an adult. Neuroimaging revealed a well-enhanced mass in the left frontal lobe. And it was completely resected. The results of the pathological and immunohistochemical studies were consistent with the metastasized ALK+ ALCL. The clinical findings, pathologic characteristics and treatment are described.

Entities:  

Keywords:  ALCL; ALK-positive; CNS; metastasis

Mesh:

Substances:

Year:  2014        PMID: 24696735      PMCID: PMC3971325     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  13 in total

1.  Diagnosis and successful treatment of childhood primary leptomeningeal lymphoma.

Authors:  M S Felice; P A Zubizarreta; J G Rossi; A Rose; E M Alfaro; F Sackmann-Muriel
Journal:  Med Pediatr Oncol       Date:  2000-05

2.  WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview.

Authors:  E Sabattini; F Bacci; C Sagramoso; S A Pileri
Journal:  Pathologica       Date:  2010-06

3.  Isolated cutaneous anaplastic large cell lymphoma progressing to severe systemic disease with myocardial involvement and central nervous system infiltration.

Authors:  Yi Fan Rannan-Eliya; Karen Pulford; Rob Johnson; Ian Peart; George Kokai; Colin Baillie; Kamel Ait-Tahar; Barry Pizer
Journal:  Pediatr Blood Cancer       Date:  2008-04       Impact factor: 3.167

4.  Pediatric primary leptomeningeal lymphoma treated without cranial radiotherapy.

Authors:  Takashi Taga; Yuko Sakaue; Yuko Anzai; Yoshihiro Takeuchi; Shigeru Ohta
Journal:  Pediatr Blood Cancer       Date:  2007-04       Impact factor: 3.167

5.  ALK+ lymphoma: clinico-pathological findings and outcome.

Authors:  B Falini; S Pileri; P L Zinzani; A Carbone; V Zagonel; C Wolf-Peeters; G Verhoef; F Menestrina; G Todeschini; M Paulli; M Lazzarino; R Giardini; A Aiello; H D Foss; I Araujo; M Fizzotti; P G Pelicci; L Flenghi; M F Martelli; A Santucci
Journal:  Blood       Date:  1999-04-15       Impact factor: 22.113

Review 6.  The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.

Authors:  Elias Campo; Steven H Swerdlow; Nancy L Harris; Stefano Pileri; Harald Stein; Elaine S Jaffe
Journal:  Blood       Date:  2011-02-07       Impact factor: 22.113

Review 7.  Primary systemic anaplastic large-cell lymphoma (CD30+): advances in biology and current therapeutic approaches.

Authors:  C Fiorani; G Vinci; S Sacchi; G Bonaccorsi; T Artusi
Journal:  Clin Lymphoma       Date:  2001-06

8.  Spread of malignant lymphoid cells into rat central nervous system with intact and disrupted blood-brain barrier.

Authors:  R Aho; S Vaittinen; K Jahnukainen; H Kalimo
Journal:  Neuropathol Appl Neurobiol       Date:  1994-12       Impact factor: 8.090

Review 9.  The anaplastic lymphoma kinase in the pathogenesis of cancer.

Authors:  Roberto Chiarle; Claudia Voena; Chiara Ambrogio; Roberto Piva; Giorgio Inghirami
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

10.  The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.

Authors:  H Stein; D Y Mason; J Gerdes; N O'Connor; J Wainscoat; G Pallesen; K Gatter; B Falini; G Delsol; H Lemke
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.